Hadfield succeeds Dr. Ralph Highnam, who transitions to Chief Science & Innovation Officer, as Volpara accelerates global growth in AI-driven cancer detection and prevention. ...
The next-generation femtosecond laser enhances surgical precision, reduces treatment time, and integrates AI-driven features, reinforcing ZEISS’ leadership in refractive surgery innovation....
With an upcoming launch in Korea, Olympus strengthens access to its minimally invasive iTind procedure, enhancing patient care and easing hospital capacity pressures for men with benign prostatic hyperplasia (BPH)....
New real-time, self-adjusting deep brain stimulation system transforms Parkinson’s care with personalized neuromodulation...
Indian MedTech leader Meril introduces a new range of advanced cardiovascular surgical products, including biomechanically engineered valves, high-performance sutures, and precision-driven cardiac needles, reinforcing its commitment to clinical excellence and patient safety. ...
With CE Mark approval, CathVision’s AI-powered ECGenius System is set to launch in the European market, enhancing real-time electrogram recording and clinical decision-making for healthcare providers....
In collaboration with HaDEA and HERA, Ginkgo leads the RANGER project to create a point-of-care metagenomic sequencing device, aiming for 6-hour turnaround diagnostics to revolutionize pandemic preparedness and hospital triage across Europe. ...
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...
With advanced SBOM management, automated vulnerability tracking, and FDA-ready reports, Helm reduces risk, lowers costs, and accelerates regulatory approval for medical device manufacturers....
With CE Mark certification, the AI-powered ECGenius System is now approved for commercialization in the European Economic Area, enhancing real-time electrogram recording and clinical decision-making for healthcare providers....
